AbbVie falls after trimming 2026 profit forecast
ABBV•Shares fall after forecast cut
Shares of drugmaker AbbVie ABBV.N fall 4.4% to $246 premarket.
The company trims its 2026 profit forecast between $13.87 and $14.07, compared with its prior range of $13.91 to $14.11.
Analysts expect adjusted profit to be $14.08 per share, LSEG data showed.
Quarterly results beat estimates
AbbVie posts Q2 adjusted profit of $3.65 per share versus analysts' estimate of $3.60 per share.
It reports Q2 revenue of $16.99 billion versus estimates of $16.77 billion.
As of the last close, the stock was up 12.7% year to date.
